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Abstract
Background: Etiology of complex disorders, such as cataract and neurodegenerative diseases including age-related
macular degeneration (AMD), remains poorly understood due to the paucity of animal models, fully replicating the
human disease. Previously, two quantitative trait loci (QTLs) associated with early cataract, AMD-like retinopathy,
and some behavioral aberrations in senescence-accelerated OXYS rats were uncovered on chromosome 1 in a
cross between OXYS and WAG rats. To confirm the findings, we generated interval-specific congenic strains, WAG/
OXYS-1.1 and WAG/OXYS-1.2, carrying OXYS-derived loci of chromosome 1 in the WAG strain. Both congenic
strains displayed early cataract and retinopathy but differed clinically from OXYS rats. Here we applied a high-
throughput RNA sequencing (RNA-Seq) strategy to facilitate nomination of the candidate genes and functional
pathways that may be responsible for these differences and can contribute to the development of the senescence-
accelerated phenotype of OXYS rats.
Results: First, the size and map position of QTL-derived congenic segments were determined by comparative
analysis of coding single-nucleotide polymorphisms (SNPs), which were identified for OXYS, WAG, and congenic
retinal RNAs after sequencing. The transferred locus was not what we expected in WAG/OXYS-1.1 rats. In rat retina,
15442 genes were expressed. Coherent sets of differentially expressed genes were identified when we compared
RNA-Seq retinal profiles of 20-day-old WAG/OXYS-1.1, WAG/OXYS-1.2, and OXYS rats. The genes most different in
the average expression level between the congenic strains included those generally associated with the Wnt,
integrin, and TGF-b signaling pathways, widely involved in neurodegenerative processes. Several candidate genes
(including Arhgap33, Cebpg, Gtf3c1, Snurf, Tnfaip3, Yme1l1, Cbs, Car9 and Fn1) were found to be either polymorphic
in the congenic loci or differentially expressed between the strains. These genes may contribute to the
development of cataract and retinopathy.
Conclusions: This study is the first RNA-Seq analysis of the rat retinal transcriptome generated with 40 mln
sequencing read depth. The integration of QTL and transcriptomic analyses in our study forms the basis of future
research into the relationship between the candidate genes within the congenic regions and specific changes in
the retinal transcriptome as possible causal mechanisms that underlie age-associated disorders.
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Background
The last years have seen great progress in understanding
the pathophysiology of complex age-related diseases
such as cataract and age-related macular degeneration
(AMD): two of the major leading causes of visual
impairment and blindness of elderly people in industrial
countries. The molecular pathways underlying their
onset and progression have yet to be described. Early
stages of these diseases cannot be studied in humans,
and existing animal models have severe limitations in
recapitulating the disease progression [1-3].
We have previously shown that OXYS rats sponta-
neously develop a phenotype similar to human aging-
associated disorders including retinopathy and cataract,
with clinical, morphological, and molecular features
similar to human AMD and senile cataract [4-8]. As we
reported recently, neurodegenerative processes observed
in OXYS rats are similar to those seen in Alzheimer’s
disease [9-11]. This animal model is successfully used to
study the pathways and molecular alterations implicated
in the development and progression of these disorders
as well as to test new therapeutic interventions [11-16].
Nevertheless, the genetic architecture of this senes-
cence-accelerated phenotype of OXYS rats remains
poorly understood.
Analysis of quantitative trait loci (QTLs) is an unbiased
genetic approach to studies of susceptibility genes and
molecular pathways involved in diseases of complex
etiology with a strong genetic component. The usual
paradigm is to produce segregating populations derived
from “affected” and “control” strains and to search for
linkage of a complex trait to genetic markers using
sophisticated statistical techniques. The methods of QTL
analysis have long been used successfully in the studies of
hypertension [17-19], neurodegeneration [20,21] and
modifiers of pathological ocular phenotypes including
retinal degeneration in mouse models [22-25]. On the
other hand, some difficulties arise with the identification
of QTL alleles at the level of causative genes [26]. Despite
being confirmed and refined in location to a small inter-
val spanning several megabases, a single QTL still har-
bors a number of genes (or does not generally contain
annotated genes) and can act through a confluence of
multiple interactions and molecular mechanisms.
Further testing for expression differences is one of the
approaches aimed at identifying the genes underlying
phenotypic differences [27]. In systems biology, identifi-
cation of the underlying molecular pathways can be
facilitated by high-throughput analyses, particularly at
the proteomic and transcriptomic levels. RNA-Seq analy-
sis, based on the next-generation sequencing technology,
provides a far more precise quantification of transcripts
than do other methods and allows for detection of novel
transcriptomic features, e.g., novel exons and alternative
splicing variants. The RNA-Seq technology has success-
fully been used for exploration of complex traits and, par-
ticularly, for identifying the genes related to retinal
development and diseases [28-32].
Our previous QTL studies were focused on chromosome
1 and led to identification of two QTLs associated with
early cataract, retinopathy similar to human AMD, and
some behavioral aberrations in senescence-accelerated
OXYS rats in a cross between OXYS and WAG rats. One
QTL (named QTL1) was mapped to the medial region
(100.6-188.0 Mbp) and the other QTL (named QTL2) - to
the distal region (188.0-250.4 Mbp) of chromosome 1 [33].
Control WAG rats have no appreciable signs of cataract
and retinopathy (unpublished data). Two interval-specific
congenic strains, carrying OXYS-derived loci of chromo-
some 1 on the WAG strain, were generated to confirm our
findings: WAG/OXYS-1.1 and WAG/OXYS-1.2. Both con-
genic strains develop early cataract and retinopathy but are
clinically different from OXYS rats [33]. According to the
results of a preliminary histological study (unpublished),
the degenerative changes in the retina of the congenic rats
occur in the context of mass migration of mononuclear
phagocytes, e.g., into the ganglionic layer. This finding can
serve as evidence of the development of an inflammatory
process in the retinas of the congenic rats that is typical for
patients with AMD, but not for OXYS rats.
The purpose of the present study was to identify candi-
date genes likely to be involved in the development of
early cataract and retinopathy in rats of congenic and
OXYS strains by analyzing the RNA-Seq data obtained
from retinal RNA samples.
Results
A previous study [33,34] showed that early cataract and
AMD-like retinopathy in senescence-accelerated OXYS
rats are associated with two QTLs located on chromo-
some 1, with the cumulative genomic length of 149.8
Mbp. We generated two interval-specific congenic
strains, WAG/OXYS-1.1 and WAG/OXYS-1.2, carrying
OXYS-derived chromosome 1 loci in the WAG genetic
background. To map QTLs to the congenic loci and to
facilitate nomination of the candidate genes responsible
for the OXYS phenotype, we examined the retinal tran-
scriptome of 20-day-old WAG/OXYS-1.1, WAG/OXYS-
1.2, and OXYS strains using RNA-Seq. One sample of
the WAG strain (three 3-month-old animals pooled) was
processed, sequenced, and the reads were aligned to the
rat genome (Rnor_5.0 assembly) to obtain a characteristic
set of single-nucleotide polymorphisms (SNPs) for the
second parental strain.
Identifying the congenic regions on chromosome 1
The comparative analysis of SNPs specific to the OXYS,
WAG, and congenic strains allowed us to identify the
Korbolina et al. BMC Genomics 2014, 15(Suppl 12):S3
http://www.biomedcentral.com/1471-2164/15/S12/S3
Page 2 of 17
regions of chromosome 1 that came from the OXYS
strain and were introgressed into the WAG/OXYS-1.1
and WAG/OXYS-1.2 constructed strains (Figure 1).
We found that the OXYS segments introgressed into the
WAG/OXYS-1.1 strain corresponded approximately to
the positions of 8.9 × 107-9.7 × 107 bp plus 1.04 × 108-
1.05 × 108 bp of chromosome 1. The OXYS segment
introgressed into the WAG/OXYS-1.2 strain corresponded
approximately to the positions of 1.78 × 108-2.1 × 108 bp
plus 2.34 × 108-2.75 × 108 bp of chromosome 1. We
found no additional transferred extended loci on other
chromosomes in each case (Figure 2). So, the QTL-
derived congenic segments were confined to the cumu-
lative genomic segment of approximately 81.1 Mbp.
There were 195 and 1013 ENSEMBL IDs within the
WAG/OXYS-1.1 and WAG/OXYS-1.2 congenic seg-
ments, respectively, according to the results of data
mining with the Encode project [35,36].
The global transcriptome
Of 26405 genes in the reference genome rno5, our
reads were uniquely mapped to 15442 genes (Additional
file 1), with at least 10 counts on average. Differential
expression of genes among the congenic WAG/OXYS-
1.1 and WAG/OXYS-1.2 and parental OXYS strains
was assessed using the DESeq package [37], resulting in
the lists of 81 and 231 differentially expressed (DE)
genes identified in the WAG/OXYS-1.1 versus OXYS
and WAG/OXYS-1.2 versus OXYS comparisons, respec-
tively (at padj<0.1 and the cutoff of |log2FC|≥1). We
identified only 3 ENSEMBL IDs for genes significantly
differentially expressed between the WAG/OXYS-1.1
and WAG/OXYS-1.2 congenic strains (padj<0.1):
ENSRNOG00000009373, ENSRNOG00000042565, and
ENSRNOG00000001273. Thus, in the WAG/OXYS-1.1
versus WAG/OXYS-1.2 comparison the strategy was to
use Gene Ontology (GO) enrichment tools to test for
Figure 1 The distribution of SNPs specific to the parental strains, on chromosome 1 of the congenic rats: WAG/OXYS-1.1 (panel A)
and WAG/OXYS-1.2 (panel C). Panel B shows a plot of distribution of retinopathy linkage probability (LOD score) among the F2 progeny
derived from OXYS and WAG strains at age 3 months (using microsatellite markers on chromosome 1). The dotted vertical line at LOD = 2.0 is
the threshold for suggestive statistical significance. Red bars correspond to individual SNPs, specific to WAG rats, blue - to OXYS rats. COUNT - a
number of coding SNPs for 1 Mbp. The OXYS-derived loci of chromosome 1 transferred to the recipient WAG genome during the construction
of the corresponding congenic strains are shown as green (expected) and blue (the congenic segment) inserts, to the left of the linkage map.
The blue dotted lines are designed to compare the certain congenic loci between the panels. Note, that the transferred locus was not what we
expected in WAG/OXYS-1.1 rats.
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functional categories that are enriched with the genes that
are most different in the average expression level. Figure 3
shows the Venn diagram visualizing the overlapping
results between the sets of DAVID IDs for DE genes
found in the WAG/OXYS-1.1 versus OXYS, WAG/
OXYS-1.2 versus OXYS, and in WAG/OXYS-1.1 versus
WAG/OXYS-1.2 (speculative observations) comparisons.
The DE genes were subjected to various further analyses.
Pathway analysis
To identify pathways and biological functions associated
(more than by chance) with the DE genes, we carried
out gene annotation enrichment analysis using 2 online
bioinformatic tools: DAVID [38] and WebGestalt
[39,40]. The most representative GO terms are shown
in the corresponding list of Additional file 2. A complete
set of DAVID analyses of the entire lists of DE genes is
presented in Additional file 2. Pathway analysis was also
performed for separate up- and down-regulated DE
groups (Additional file 3).
In the WAG/OXYS-1.1 versus OXYS comparison,
DAVID revealed significant enrichment in GO terms
relevant to the Srb-mediator complex, peroxisomes, and
regulation of neurotransmitter release. Significant
enrichment in GO terms, including the MHC class I
protein complex, antigen processing and presentation,
wound healing, a response to wounding, negative regula-
tion of natural killer cell-mediated cytotoxicity, and Ca2
+binding was obtained in other than the WAG/OXYS-
1.2 versus OXYS DE gene set (Additional file 2). Some
GO terms obtained using these two DE gene sets were
relevant. Aside from GO terms related to extracellular
matrix components, the analysis of both WAG/OXYS-
1.1 versus OXYS and WAG/OXYS-1.2 versus OXYS DE
sets of genes revealed categories related to fatty acid
metabolic processes, the inflammatory response, and
DNA ligation during DNA repair.
DAVID revealed enrichment in GO terms relevant to
neuronal differentiation, blood vessel development, mel-
anin biosynthetic processes, cell-cell signaling, mem-
brane rafts, wide pore channel activity, regulation of
transmission of nerve impulses, and transcription factor
activity in a set of genes most variable in expression
between the WAG/OXYS-1.1 and WAG/OXYS-1.2
Figure 2 The distribution of SNPs, specific to the parental OXYS and WAG strains, on all chromosomes of the congenic rats: WAG/
OXYS-1.1 (panel A) and WAG/OXYS-1.2 (panel B). The vertical axis shows counts-the number of coding SNPs for 10 Mbp; the horizontal axis
shows the length (in Mbp) of all chromosomes in genome, arranged in numerical order, where the chromosome boundaries are indicated by
the red vertical dotted lines. The loci derived from OXYS parental strain are located on chromosome 1 of the congenic strains. Note, that no
additional transferred extended loci are found on other chromosomes in each case.
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congenic strains. The enriched KEGG pathway categories
unique for this comparison were the Wnt signaling path-
way, TGF-b signaling pathway, cadherin signaling path-
way, melanogenesis, and Alzheimer’s disease-presenilin
pathway, where some named categories shared common
genes from the five: Bace2, Wnt16, Wnt6, Cdh1, and
Cdh3, members of the set of notably variable in average
expression genes (Additional file 2, 3).
Cross-referencing of QTL expression differences
The overlap between a gene’s nomination via its presence
within a QTL-derived congenic segment and its differen-
tial expression was analyzed first by cross-referencing of
the lists of QTL genes with 81 and 231 DE genes identified
in the WAG/OXYS-1.1 versus OXYS and WAG/OXYS-
1.2 versus OXYS comparisons, respectively (Additional
file 1). Thereby we identified 4 DE genes located only
within the second congenic locus (introgressed into the
WAG/OXYS-1.2 strain): Zp2, Ifit1, Col17a1, and Snurf.
Polymorphisms
An allelic effect could be brought about at a different
level of gene expression and as a result of an altered
coding sequence. Further, the comparative analysis of
non-synonymous coding SNPs (revealed for OXYS and
congenic strains but not for WAG strain) was conducted
with the focus only on the genes located within the
congenic loci. Analysis using the online Variant Effect
Predictor tool [41] revealed that non-synonymous substi-
tution of amino acid residues in the protein products of
6 genes located within the congenic loci in WAG/OXYS-
1.1 rats and of 13 genes located within the congenic loci
in WAG/OXYS-1.2 rats may affect the function of the
proteins (Table 1). The possible impact of an amino acid
substitution on the structure and function of the protein
was predicted using the SIFT algorithm, scale-invariant
feature transform [42]. These 19 new candidate genes
were not among the genes differentially expressed
between the congenic carrier and OXYS strains (Addi-
tional file 1).
Discussion
To identify candidate genes that are potentially involved in
the development of early cataract and retinopathy in
OXYS and derived congenic rats, we integrated transcrip-
tomic data (obtained from retinas of 2 parental inbred:
senescence-accelerated OXYS and WAG strains; and from
retinas of 2 derivative congenic strains) with the results of
previous QTL mapping of cataract and AMD-like retino-
pathy on chromosome 1 [33,34]. The analyses converged
on a set of genes, including transcription factors (Table 1,
Additional file 1), as the catching candidates (located
within any of QTL-derived congenic regions or represent-
ing DE candidates), likely to be associated with the senes-
cence-accelerated phenotype in rats.
Congenic loci
In our previous study [33] the identification of genetic
loci responsible for the trait of senescence-accelerated
phenotype in OXYS rats was performed by QTL-analy-
sis on hybrid F2 population aged 3-4 months and bred
by a reciprocal cross between OXYS and WAG rats.
Chromosome 1 showed significant associations between
retinopathy and two loci: a) the locus marked by micro-
satellite markers D1Rat30 - D1Rat219 (named QTL1);
and b) the locus marked by microsatellite markers
D1Rat219 - D1Rat81 (named QTL2) (see Figure 1, panel
B). Early cataract development was found significally
associated with the locus in the region of the microsatel-
lite markers D1Rat219 - D1Rat81 (QTL2). To determine
the effects of these two QTLs, we generated two inter-
val-specific congenic strains by transferring chromosome
1 regions from OXYS on WAG background with the
transfer controlled by limiting microsatellite markers.
Both congenic strains (named WAG/OXYS-1.1 and
WAG/OXYS-1.2, respectively) display early cataract and
retinopathy development. Thus, we confirmed that
genes located in the analyzed regions of chromosome 1
are associated with the development of eye diseases in
OXYS rats.
Figure 3 The Venn diagram visualizing the overlapping results
between the sets of ENSEMBL IDs for differentially expressed
(DE) genes found in the WAG/OXYS-1.1 versus OXYS, WAG/
OXYS-1.2 versus OXYS, and in WAG/OXYS-1.1 versus WAG/
OXYS-1.2 (speculative observations) comparisons. DESeq used
only uniquely mapped to the reference genome reads at the cutoff
of |log2FC |≥1.0; padj<0.1 for the WAG/OXYS-1.1 versus OXYS and
WAG/OXYS-1.2 versus OXYS DE genes. In the WAG/OXYS-1.1 versus
WAG/OXYS-1.2 comparison, the genes most different in the average
expression level (pvalue < 0.05; |log2FC |≥1.0) were tested. The
number of genes in each group is shown in the corresponding field.
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In the present study we determined the size and map
position of QTL-derived congenic segments by compara-
tive analysis of coding single-nucleotide polymorphisms
(SNPs), which were identified for OXYS, WAG, and con-
genic retinal RNAs by the means of RNA-Seq. We found
that a certain congenic locus, introgressed into the
WAG/OXYS-1.1 strain, unexpectedly was not the locus
in the vicinity of microsatellite markers D1Rat30 and
D1Rat219 (Figure 1, panel B), but rather the locus
marked by D1Rat224 - D1Rat30, which yielded LOD of
1.38 for linkage with cataract development in OXYS rats
according to our unpublished data. Figuring out the rea-
son for this discrepancy is beyond the objectives of the
present study because WAG/OXYS-1.1 rats carry the
OXYS-derived locus of chromosome 1 and develop catar-
act and retinopathy. Thus, the influence of genes located
in the transferred locus on the disease development in
OXYS and congenic WAG/OXYS-1.1 rats can be
Table 1 Genes (within the congenic loci) containing non-synonymous coding SNPs with potential relevance to the
senescence-accelerated phenotype in OXYS rats
Gene
symbol












Congenic locus in WAG/OXYS-1.1 strain
Hps5 Hermansky-Pudlak syndrome 5 C 667 223 R/G Aga/
Gga
tolerated (0.46) -
Hps5 Hermansky-Pudlak syndrome 5 T 188 63 R/K aGg/
aAg
tolerated (0.25) -
Cic capicua transcriptional repressor A 1517 506 C/Y tGc/tAc tolerated (0.08) -
Arhgap33 RhoGTPase activating protein 33 T 3466 1156 D/N Gat/Aat deleterious (0) -
Lin37 lin-37 homolog (Caenorhabditis elegans) A 547 183 P/S Cca/Tca tolerated (0.18) -
Cebpg CCAAT/enhancer binding protein (C/EBP), g T 410 137 S/N aGc/
aAc
tolerated (0.45) -
Nudt19 nudix (nucleoside diphosphate linked
moiety X)-type motif 19
C 1015 339 S/G Agc/
Ggc
tolerated (0.42) -
Congenic locus in WAG/OXYS-1.2 strain
Ccp110 centriolar coiled coil protein 110 kDa A 868 290 D/N Gat/Aat tolerated (0.17) rs197588212
Gtf3c1 general transcription factor IIIC, polypeptide
1, a
A 6379 2127 R/C Cgt/Tgt - rs8156681
Gtf3c1 general transcription factor IIIC, polypeptide
1, a
C 5692 1898 T/A Aca/
Gca
tolerated (0.75) rs198509438
Gtf3c1 general transcription factor IIIC, polypeptide
1, a
C 5021 1674 N/S aAt/aGt tolerated (0.74) rs106585674
Rabep2 rabaptin, RAB GTPase binding effector
protein 2
C 1007 336 I/T aTc/aCc tolerated (1) rs8153744
Aldoa aldolase A, fructose-bisphosphate C 493 165 M/V Atg/
Gtg
tolerated (0.58) rs8160964
Inpp5f inositol polyphosphate-5-phosphatase F C 3075 1025 L/F ttG/ttC tolerated (0.44) -
Psat1 phosphoserine aminotransferase 1 T 316 106 A/T Gct/Act tolerated (0.61) -
Tjp2 tight junction protein 2 T 767 256 R/H cGc/
cAc
tolerated (0.59) rs198995028
Ak3 adenylate kinase 3 T 368 123 L/Q cTa/
cAa
tolerated (0.66) rs197195051
Ric1 RAB6A GEF complex partner 1 G 229 77 N/D Aac/
Gac
tolerated (1) rs197794754
RGD1311595 similar to KIAA2026 protein C 2613 871 I/M atA/atG tolerated (1) rs198237726
Sfxn3 sideroflexin 3 A 927 309 N/K aaC/
aaA
tolerated (0.92) rs8163692
Nolc1 nucleolar and coiled-body phosphoprotein 1 A 421 141 E/K Gag/
Aag
tolerated (0.61) rs8165446
Pdcd11 programmed cell death 11 C 3005 1002 I/T aTc/aCc tolerated (1) -
The SNP quality integral parameter threshold (in Samtools/Bcftools) was Qual> 180, and the consequence according to the Variant Effect Predictor tool, VEP [41]
was “missense”. Only 1 SNP, located in the Arhgap33 gene, was predicted to significantly affect protein structure (marked as “deleterious” by VEP). Position =
position in base pairs (for CDS sequence) or in amino acid residues (for protein); AA = amino acid residue; colocated variation is presented according to the
ENCODE data.
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considered confirmed [43]. A possible explanation is that
the congenic strain resulting from selecting only 1 locus
of interest will have flanking donor chromosomal seg-
ments equal on average to 100/N cM on each side
[43,44], where N is the number of backcrosses and 1 cM
is equivalent to 2 × 106 bp of DNA in mice (and presum-
ably in rats). After 8 backcrosses during the production
of congenic strains in our study [33], the flanking DNA is
on average ~12.5 cM on each side of the selected marker
or 25 cM in size.
The locus, transferred from the OXYS to WAG/
OXYS-1.2 strain was the expected one when introgres-
sing the locus marked by D1Rat30 and D1Rat219 micro-
satellites. On other chromosomes, we did not find any
extended OXYS-derived loci that were additionally
transferred to any congenic strain (see Figure 2).
Here we report that the QTL-derived segments intro-
gressed from OXYS rats are confined to the cumulative
genomic length of ~81.1 Mbp and distinctly differentiate
the WAG/OXYS-1.1 strain from WAG/OXYS-1.2 strain.
The transcriptome
Because it has been suggested that variation in gene
expression is an important contributor to the genetic
architecture of complex traits [27], unraveling the
changes in transcriptomic signatures should provide
further understanding of the susceptible genetic loci that
are involved in the pathogenesis of age-associated disor-
ders, including AMD [32,45,46]. Recent genetic discov-
eries demonstrate that the pathogenic pathways in AMD
are related to those in Alzheimer’s disease among other
disorders [47,48], thereby supporting the notion that
AMD is an ocular manifestation of systemic disease pro-
cesses [49], with a role for inflammation and immune
processes in AMD pathogenesis [46,50,51].
We reported previously that AMD-like retinopathy is
accompanied by downregulation of immune response
genes and by changes in mRNA levels of a number of
genes related to mitochondrial function in the OXYS
retina at ages 3 and 18 months [52]. Impairment of the
appropriate inflammatory response in OXYS rats was also
observed in other tissues in a model of collagen-induced
arthritis (our unpublished data, manuscript in prepara-
tion). In addition, we previously reported reduced strength
of a delayed hypersensitivity reaction and a decline of
T-cell-mediated immunity in OXYS rats [53]. One possi-
ble cause of the observed immune imbalance can be
attributed to the accelerated thymus involution in OXYS
rats [13]. Accordingly, we reported that the development
of AMD-like retinopathy in OXYS rats is associated with
an imbalance in immune and inflammatory responses [52]
and carefully hypothesized that the impairment of
immune function in OXYS rats may be associated with
systemic neurodegenerative processes. The results of the
present study support this hypothesis. When it comes over
the GO terms, the imbalance of immune and inflamma-
tory responses is observed at age 20 days between OXYS
and both derivative congenic strains. Thus, the GO terms
related to negative regulation of leukocyte-mediated cyto-
toxicity and positive regulation of T-cell-mediated cyto-
toxicity are downregulated in the WAG/OXYS-1.2 retina
compared to OXYS retina; however, the GO term related
to MHC class I protein complex is upregulated in this
comparison. As for genes from the “Antigen processing
and presentation” GO category, these are among up- and
down-regulated sets between WAG/OXYS-1.2 and OXYS
rats (Additional file 3). The results of pathway analysis are
also suggestive of differences in DNA and lipid metabo-
lism between the congenic and OXYS rats.
Candidate genes in the congenic regions
Integration of RNA-Seq data from congenic rats with the
results of QTL mapping reduces the number of posi-
tional candidates from the genes located throughout two
QTL regions [9,34] to 19 candidate genes within the
defined congenic loci. These genes contain non-synon-
ymous coding polymorphisms that were revealed in the
cDNA sequence of OXYS and derived congenic rats, but
were not detected in the cDNA sequence of WAG rats
(Table 1). None of 19 genes were defined as differentially
expressed between the congenic carrier and parental
OXYS strain (Additional file 1). The identified poly-
morphisms likely have functional consequences accord-
ing to web-enabled Variant Effect Predictor Tool, thus
may contribute to the senescence-accelerated phenotype
of OXYS rats and to the differences in cataract and reti-
nopathy development between congenic and OXYS
strains. The consequences for only one of the coding
non-synonymous SNPs described here, located in the
Arhgap33 gene within the WAG/OXYS-1.1 congenic
locus, are expected to significantly affect protein struc-
ture (labeled “deleterious” by the Variant Effect Predictor
tool). Arhgap33 codes the member of the Rho family of
GTPases, which can trigger signal transduction events in
the regulation of actin cytoskeleton [54]. Members of this
family modulate endocytic trafficking and a-secretase
cleavage of the amyloid precursor protein (APP) [55],
including interaction with BACE1 [56].
The label for the other missense SNPs in the congenic
loci is “tolerated”. Nevertheless, both congenic loci contain
positional candidate genes that are of interest because of
their potential contribution to the disease-associated
pathways.
Nudt19, nudix (nucleoside diphosphate-linked moiety
X)-type motif 19, is a potential biomarker of early
stages of Alzheimer’s disease [57] and, along with mul-
tiple Nudix family hydrolases, may function in mRNA
decapping and maintenance of mRNA stability [58].
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The CCAAT/enhancer-binding proteins (C/EBPs) are
basic leucine zipper transcription factors that perform
important functions in regulation of cell growth and
differentiation, the inflammatory response, and hema-
topoiesis [59-62]. Biological functions of the protein
product of Cebpg, CCAAT/enhancer-binding protein
(C/EBP) g, are not well understood, but a senescence-
suppressing activity of C/EBPg, which requires its abil-
ity to heterodimerize with C/EBPb, was reported
recently [63]. CEBPG is described as a modulator of
C/EBP activity [64,65], a component of transcriptional
regulation of B-cell development [62], and as a tran-
scription factor primarily responsible for regulating
transcription of key antioxidant and DNA repair genes
in normal bronchial epithelial cells [66]. The protein
product of Lin37, the lin-37 DREAM MuvB core com-
plex component, is required for regulation of chondro-
cyte proliferation [67]. Another positional candidate
gene within the WAG/OXYS-1.1 congenic locus is Cic,
an ortholog of a Drosophila gene that is predominantly
expressed during mouse granule cell development [68].
This gene is implicated in c-erbB (Egfr) signaling and
is involved in abnormal migration of retinal pigment
epithelium (RPE) [69]. As demonstrated on Timp3
−/−mice, inhibition of EGFR signaling most likely
reduces pathological retinal neovascularization in a
mouse model of oxygen-induced retinopathy [70]. The
EGFR signaling pathway is considered a possible link
between extracellular signaling and regeneration-asso-
ciated gene expression in the injured retina [71].
In the WAG/OXYS-1.2 congenic locus, we identified 3
non-synonymous coding SNPs within the Gtf3c1 gene,
which is the general transcription factor IIIC, polypep-
tide 1a, coding a subunit of the general transcription
factor IIIC [72]. The latter may regulate rearrangement
of the nuclear architecture, allowing for coordinated
expression of activity-dependent neuronal genes [73].
In addition, 4 candidate genes without coding poly-
morphisms, identified in the present study, were located
in the second congenic locus and showed differential
expression (Additional file 1) between the WAG/OXYS-
1.2 carrier and parental OXYS strain: Zp2, Ifit1, Col17a1,
and Snurf. Note, that this fact suggests a diverse tran-
scriptional regulation which occurs against different
genetic background.
The ZP251-149 sperm-binding domain is necessary for
human and mouse gamete recognition and penetration
through the zona pellucida, the extracellular glycocalyx
that surrounds an oocyte. GO annotations related to this
gene include “acrosin binding” and “coreceptor activity”
[74]. The Col17a1gene encodes the a chain of type XVII
collagen, a transmembrane protein that is a structural com-
ponent of hemidesmosomes, whose mutations result in a
blistering disorder non-Herlitz junctional epidermolysis
bullosa (JEB-nH) [75]. Ifit1 encodes a protein containing
tetratrico peptide repeats that was originally identified as a
protein induced upon treatment with interferon; it
belongs to the “cytokine signaling in the immune sys-
tem” category according to REACTOME pathway data-
base [76]. This protein may inhibit viral replication
and translation initiation [77,78].
Snurf, the SNRPN (small nuclear ribonucleoprotein N)
gene, was found strongly upregulated in WAG/OXYS-
1.2 retina when compared to OXYS (log2FC =
-3,01324). This is the best characterized of genes asso-
ciated with Prader-Willi syndrome (PWS) and Angel-
man syndrome (AS): neurobehavioral disorders that are
caused by a deficiency in imprinted-gene expression
from paternal and maternal chromosome 15q11-q13,
respectively. The data from human and mouse models
point to SNURF’s being a protein that is produced along
with SmN from a bicistronic transcript (this phenom-
enon is rarely observed in eukaryotes), with each cistron
potentially playing a role in the disease [79,80]. The
highly conserved activator sequence in Snrpn intron 1
demonstrates developmental dynamic changes of DNA
methylation and has a methylation-sensitive enhancer
activity in rodents; thereby it may control tissue-specific
expression of transcripts [81]. Note, that the ubiqui-
tously expressed transcription factor 1, Sp1, interacts
with the SNURF protein, according to the Biological
General Repository for Interaction Datasets, BioGRID
[82]. Sp1 is reported to play a crucial role at early stages
of hematopoietic specification [83] and to be involved in
photoreceptor-specific transcription either directly or
through competition [84] as well as in the regulation of
expression of the vascular endothelial growth factor
receptor 3 (VEGFR-3) [85].
Candidate DE genes
Recently, we showed that senescence-accelerated OXYS
rats are a promising model for studies of the mechan-
isms of the neurodegenerative processes similar to those
seen in Alzheimer’s disease [9-11]. In these rats, beha-
vioral alterations and learning and memory deficits
develop by the age of 3 months, accompanied by mito-
chondrial structural abnormalities, such as formation of
cristae-free regions inside mitochondria by the age of 4
months. Moreover, we established a relationship
between the retinopathy development in OXYS rats
with alterations in the Alzheimer’s disease metabolic
pathway observed in the retina at the ages of 3 and 18
months [9].
In the present study, we uncovered candidate genes
that are already differentially expressed in the retina of
congenic rats at the age of 20 days - when compared
with each other and with OXYS rats–and are associated
with the Alzheimer’s disease pathway or with
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maintenance of mitochondrion structure and function.
Some of these genes are mentioned below.
The comparison between WAG/OXYS-1.1 and
WAG/OXYS-1.2 strains
Inbred WAG rats used in our study are of normal phe-
notype. So this comparison was intended to give the
candidate DE genes which are associated with the differ-
ent OXYS-derived loci of chromosome 1 transferred to
congenic strains and potentially drive early cataract and
retinopathy onset and progression in congenic rats.
Simultaneously, we hypothesized that the same DE can-
didate genes can contribute to the development of the
senescence-accelerated phenotype of OXYS rats.
As mentioned above, we identified only 3 ENSEMBL
IDs for genes significantly differentially expressed
between the WAG/OXYS-1.1 and WAG/OXYS-1.2
congenic strains (padj<0.1): ENSRNOG00000009373,
ENSRNOG00000042565, and ENSRNOG00000001273.
The last is related to Psmg3, proteasome (prosome, macro-
pain) assembly chaperone 3, which is 1 of 14 distinct gene
products essential for biogenesis of mammalian 20S pro-
teasomes [86]. 20S proteasome is a catalytic core of the
26S proteasome, a central enzyme in the degradation of
ubiquitin-conjugated proteins. This protein-degradation
system might be a potential therapeutic strategy for AD
and other tauopathies. The hypothesis that failure of pro-
teasomal and non-proteasomal proteolytic clearance
mechanisms leads to tau accumulation and progressive
neurofibrillary degeneration in AD has been supported in
a number of papers [87-89].
However, we could make some speculative assumptions
regarding the results of the present study, based on the set
of genes that are most variable in expression between the
WAG/OXYS-1.1 and WAG/OXYS-1.2 congenic strains
(with the cutoff of pvalue < 0.05; |log2FC|≥1). The list of
most variable in expression genes from this comparison
includes Bace2, b-site APP-cleaving enzyme 2, a paralog of
Bace1 (a promising drug target in AD). We can hypothe-
size that such a difference is due to the differences in
molecular networks, underlying the two congenic loci
against the WAG background. Although normal functions
of both enzymes, Bace1 and Bace2, are still unclear [90], it
has been shown that astrocytes possess b-secretase activity
and produce Ab because of the activity of BACE2 [91].
BACE2 variants have an effect on the age of onset of
dementia in people with Down syndrome [92]. Among
other genes most variable in expression in this comparison
are Wnt16 and Wnt6 (upregulated in the WAG/OXYS-1.1
group), the members of wingless-type MMTV integration
site family and of the Wnt signaling pathway. The Wnt
proteins perform a key function during various stages
of retinal development and disease, e.g., they mediate
angiogenesis and choroidal neovascularization, a severe
complication of AMD [93]. Wnt proteins have also been
implicated in AD [94,95]. The other gene upregulated in
the WAG/OXYS-1.1 strain is the Dkk1gene, the product
of which influences eye development from a defined devel-
opmental time point on, and is essential for lens separa-
tion from the surface ectoderm [96]. The function of Dkk1
has not been analyzed in detail in terms of eye develop-
ment, but most likely the resulting protein acts in a dose-
dependent manner, as a competent antagonist of canonical
Wnt signaling [97,98].
NFATC4 (a nuclear factor of activated T-cells, cytoplas-
mic, calcineurin-dependent 4) is a transcriptional factor
involved in the control of the flow of genetic information
and in modulation of diverse cellular activities [99]. Nfatc4
exhibits a higher-than-average expression level in the
WAG/OXYS-1.1 retina compared to WAG/OXYS-1.2.
Accumulating evidence has demonstrated that NFATc4
exerts a proapoptotic effect in multiple diseases, and
might participate in retinal ganglion cell apoptosis [100].
The proteoglycan decorin, encoded by the Dcn gene from
the group, may also play a role in the differentiation of ret-
inal ganglion cells [101] and is involved in hypoxic retinal
damage, significantly reduce in expression in oxygen-
induced retinopathy [102,103].
The comparisons of retinal transcriptome profiles of
the congenic and OXYS strains
These comparisons were intended to give the DE genes
associated with phenotypic differences between parental
OXYS and derivative congenic strains. Candidates from
this set are potentially involved in molecular pathways
underlying cataract and retinopathy progression, as well as
in the development of other features of the senescence-
accelerated phenotype in OXYS rats.
Candidate DE genes unique in the WAG/OXYS-1.1
versus OXYS comparison
Ephx2, soluble epoxide hydrolase - a key enzyme in the
metabolism and termination of action of epoxyeicosa-
trienoic acids, is significantly downregulated in WAG/
OXYS-1.1 rats when compared to OXYS. Transgenic
expression of Ephx2 in the endothelium is known to
result in impaired endothelium-dependent vasodilation
in the cerebral circulation [104].
Cabp1, a Ca2+-binding protein (CaBP), and the calcium
sensor protein caldendrin [105] are alternatively spliced
variants of a subfamily of CaBPs with high homology to
calmodulin. Caldendrin is abundantly expressed in neu-
rons and is thought to perform an important function at
different stages of synaptodendritic Ca2+ signaling
[106,107]. Thus, caldendrin immunoreactivity is displayed
by subpopulations of most retinal cell classes, with the
exception of glial cells [108]. In the mouse brain, CaBP1/
caldendrin is localized both pre- and post-synaptically,
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where it may regulate Ca2+ signaling and excitability in
selected groups of excitatory and inhibitory neurons [109].
The product of Elovl1 gene ortholog, ELOVL fatty
acid elongase 1, participates in the metabolism of very
long-chain fatty acids (VLCFAs) and a variety of inher-
ited diseases, such as ichthyosis, macular degeneration,
myopathy, mental retardation, and demyelination, which
are caused by mutations in the genes encoding VLCFA-
metabolizing enzymes [110,111].
Cd14, encoding the CD14 molecule, is significantly
downregulated in WAG/OXYS-1.1 rats compared to
OXYS strain. It is shown that fibrillar amyloid b (Ab) can
directly interact with Toll-like receptor 2 (TLR2), TLR4,
and CD14 to induce microglial Ab phagocytosis at the
initial stages and neuroinflammatory responses at the late
stages of Alzheimer’s disease [112]. In particular, AD is
characterized by the formation of insoluble deposits of Ab
associated with a robust microglia-mediated inflammatory
response within the parenchyma of the brain. The involve-
ment of CD14and TLRs in microglial activation was also
reported, and it was suggested, that CD14 is a critical reg-
ulator of the microglial inflammatory response that acts to
modulate Ab deposition [113,114].
Is notable, that Mrps10, MRPS10 mitochondrial riboso-
mal protein S10, from this set of DE genes (upregulated
in WAG/OXYS-1.1 rats when compared to OXYS)
shows a tendency to be involved in regulation of the life-
span according to reverse transcriptase quantitative PCR
(RT-qPCR) analysis using 2 genetic backgrounds [115].
Candidate DE genes unique in the WAG/OXYS-1.2 versus
OXYS comparison
The plasma membrane in eukaryotic cells contains
microdomains that are enriched in certain glycosphingo-
lipids, gangliosides, and sterols (such as cholesterol) and
form membrane/lipid rafts that play a role in several cel-
lular functions or characteristics including polarity of
endothelial and epithelial cells, cell migration, mechano
transduction, lymphocyte activation, neuronal growth,
and signaling in a variety of disease settings [116]. Sdc1,
syndecan 1, downregulated in the WAG/OXYS-1.2 strain
when compared to OXYS rats, is a highly conserved mul-
tifunctional receptor [117]. Syndecan 1 was previously
shown to undergo raft-dependent endocytosis upon clus-
tering, regulating atherogenic postprandial remnant lipo-
proteins and molecules implicated in AD, during uptake
of the biologically and medically important ligands, such
as HIV-1 [118].
Tnfaip3, tumor necrosis factor a-induced protein 3
from this group, restricts and terminates inflammatory
responses through modulation of the ubiquitination sta-
tus of central components in the NF-B [119], IRF3
(interferon-regulatory factor 3), and apoptosis signaling
cascades. Tnfaip3 expression is necessary for prevention
of chronic inflammation and autoimmune pathology
according to studies on mice with full or conditional
gene deletion [120]. Although Tnfaip3 was ruled out as
the candidate gene for the chromosome 10 QTL for age-
related retinal degeneration in mice [23], this gene was
shown to downregulate adhesion markers, chemokine
production, and adventitial angiogenesis, all of which are
required for macrophage trafficking to sites of vascular
injury in rats [121]. Recent experimental evidence shows
that A20/TNFAIP3 is a susceptibility locus for human
inflammatory and autoimmune disorders as well as a cru-
cial gatekeeper preserving tissue homeostasis [122].
A human homolog of Yme1l1 has a similarity to mito-
chondrial conserved ATP-dependent proteinases (termed
AAA proteases) that are embedded in the mitochondrial
inner membrane, with the catalytic domain facing the
mitochondrial intermembrane space [123]. This protein
is required for resistance to apoptosis, cristae morpho-
genesis, and cell proliferation [124]. Nonetheless, how
YME1L regulates mammalian mitochondrial function is
still not clear.
Hypoxia-inducible factors (HIFs) mediate tissue-specific
CBS (cystathionine b-synthase) expression and may aug-
ment cerebral vasodilation as an adaptive response to
chronic hypoxia [125]. Moreover, ischemia/hypoxia
increases accumulation of the CBS proteins in mitochon-
dria [126], being a part of a possible general mechanism of
oxygen-sensitive regulation of mitochondrial functions by
linking the oxygenation level to accumulation/degradation
of mitochondrial heme proteins. The Cbs gene is upregu-
lated in the OXYS retina when compared to WAG/
OXYS-1.2 rats.
Carbonic anhydrase IX (CA IX)-deficient (Car9−/−)
mice exhibit abnormal locomotor activity, poor perfor-
mance on a memory test, and vacuolar degenerative
changes in the brain; these alterations seem to be age-
dependent [127]. Our data show that Car9 expression in
OXYS rats is downregulated in comparison with WAG/
OXYS-1.2 rats.
The Elf3 codes transcription factor which is highly
expressed in the retinal pigment epithelium (RPE) and can
regulate important ocular genes, such as TIMP3, in vitro
[128]. Variants of Tap2 have been shown to influence the
antigenicity of MHC class I molecules by altering
the MHC class I ligandome and to lead to reduced nega-
tive selection of CD8SP cells in rats [129].
Candidate DE genes common for the WAG/OXYS-1.1
versus OXYS and WAG/OXYS-1.2 versus OXYS
comparisons
Mediator (MED) complex is a multiprotein assembly
playing a key role in eukaryotic transcription. Alterations
of MED function are implicated in human diseases, e.g.,
alternative splicing of any MED gene may contribute to
Korbolina et al. BMC Genomics 2014, 15(Suppl 12):S3
http://www.biomedcentral.com/1471-2164/15/S12/S3
Page 10 of 17
neovascularization [130]. Although neovascularization
characterizes the end-stage of “dry” and “wet” forms of
AMD, MED8 was found upregulated and MED20 -
downregulated in both congenic strains compared to
OXYS rats at the age of 20 days.
Two DE genes from this group are associated with
maintenance of mitochondrion function: Ehhadh and
Acadm. Ehhadh, L-bifunctional enzyme, is indispensable
for the production of medium-chain dicarboxylic acids,
thus providing an explanation for the coordinated induc-
tion of mitochondrial and peroxisomal oxidative pathways
during fasting [131]. A synonymous polymorphic variation
of ACADM, acyl-CoA dehydrogenase, C-4 to C-12
straight chain (exon 11) affects splicing efficiency and may
alter fatty acid oxidation [132].
Candidate DE genes in the Alzheimer’s disease network
The DE genes found in WAG/OXYS-1.1 versus OXYS
and WAG/OXYS-1.2 versus OXYS comparisons were also
compared with human genes and their first-order interact-
ing partners of the Alzheimer’s disease network annotated
in the NetAge database, which is used for the study of
aging, longevity and age-related diseases [133]. Among
several genes, we have got a potentially relevant candidate:
fibronectin, Fn1, in the overlap. This gene encodes a glyco-
protein, a member of a common signaling network which
comprises over 40% of all proteins with multiple interac-
tions in the human interactome [134]. Fibronectin binds
to a complement protein C1q [135,136], which is induced
in the brain in response to a variety of neuronal injuries,
including AD, and blocks fibrillar amyloid-b (fAb) neuro-
toxicity [137]. C1q is also well-known risk factor for retinal
diseases related to oxidative stress, inflammation, and the
complement cascade, e.g. is associated with complement
alternative pathway of RPE cell death in AMD [138,139].
Summarizing our results, the QTL-derived loci of chro-
mosome 1 in both congenic strains contain strong poly-
morphic candidates. Moreover, promising DE candidates
are associated with each OXYS-derived locus on WAG/
OXYS-1.1 and WAG/OXYS-1.2 genetic background. It
appears that the trait of accelerated senescence under
study is truly polygenic, with more than one gene contri-
buting to OXYS-derived loci in each congenic strain even
when some of these genes turn out to be not causative. As
both congenic strains displayed early cataract and retino-
pathy but differed clinically from OXYS rats, it can be
argued that the senescence-accelerated phenotype in
OXYS rats is associated not just with the congenic loci
under study. Thorough validation studies are necessary to
address this question.
In general, the studies of variation in transcriptome
snapshots in various tissues under different influences in
congenic and parental strains can be used to explore
and test molecular networks underlying variation in
pathological phenotypes. It is possible that the systemic
factors, such as environmental [140-142], have an influ-
ence on cataract and retinopathy development and con-
tribute to differential expression of genes between
strains. For some complex diseases, viral, bacterial, or
environmental causes may ultimately prove to be of
greater importance than disease-associated genes
[141,143-145]. So, the combination of genetic factors
with known environmental determinants indicates the
highly complex nature of disease, but at the same time
also offers insights into risk prediction [146]. Finally,
some of the genes described here as candidates might
be involved in the characteristic features of the senes-
cence-accelerated phenotype that are not manifested
during eye disease progression (e.g., behavioral variation
observed in standard tests). Some of candidate genes
may become expressed with age during development of
a pathological phenotype. Thorough validation studies
are needed to address this question, yet we can specu-
late that secondary changes in gene expression patterns
between congenic and parental OXYS strains are trig-
gered in the network associated with QTL-causing
genes. In the present study, genes encoding transcrip-
tional regulators that are polymorphic or differentially
expressed in association with the congenic loci are espe-
cially good candidates.
We also identified significant transcript differences with
potential relevance to disease development in a number of
candidate genes, but we have not found SNPs within the
coding regions of these DE genes. It is likely that other fac-
tors, e.g., the presence of non-coding SNPs in elements
that regulate gene expression (including promoter and
enhancer regions and the sites of transcription factor’s
binding) contribute to the observed transcriptional differ-
ences. Their detection requires further integrative studies.
Identification of master regulators of biological pro-
cesses, including disease susceptibility and mapping of
downstream gene networks, remains a big challenge for
systems biology. Therefore, the efforts of researchers are
focused on integrating results from diverse experiments,
especially the data generated using high-throughput
methods: genome-wide association (GWA) studies,
chromatin immunoprecipitation followed by sequencing
(ChIP-Seq), and RNA-Seq [147-149]. These approaches
provide more complex information on expression levels,
differential splicing, allele-specific expression, RNA edit-
ing, and fusion transcripts resulting from chromosomal
translocations and other mutations [150-153], and also
are helpful to investigate protein-DNA interactions
[154]. As for the rat model, transcriptomic changes
across multiple organs or developmental stages are
recently beginning to be reported and integrated into
open-access databases [149,155,156]. To our knowledge,
this study represents the first analysis of the rat retinal
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transcriptome generated with 40 mln sequencing read
depth by RNA-Seq technology.
Conclusion
In this study, we carried out a comprehensive analysis of
RNA-Seq data obtained for retinas of rats from parental
and derivative congenic strains differing in the develop-
ment of cataract and retinopathy. Furthermore, the
genetic background of the trait under study obtained in
previously published QTL-analysis was determined more
accurately, and we overlaid the transcriptomic data
obtained for 20-day-old rat retinas on the results. Thus,
we obtained an unbiased list of candidate genes that
may affect disease-associated pathways. In summary, our
research of the congenic strains may facilitate dissecting
of the complex genetic architecture of the senescence-
accelerated phenotype in OXYS rats, although there is a
need for further characterization of the congenic rats.
With an improved understanding of the underlying
genetic susceptibility, researchers can hope to identify
therapeutic targets to nip AMD in the bud and to pre-
vent its progression and vision loss in humans.
Materials and methods
Animals
All animal procedures were in compliance with the Asso-
ciation for Research in Vision and Ophthalmology state-
ment for the Use of Animals in Ophthalmic and Vision
Research and the European Communities Council Direc-
tive 86/609/EES. All manipulations of rats were approved
by the Institutional Review Board #9 of the Institute of
Cytology and Genetics, the Siberian Branch of the Rus-
sian Academy of Sciences (SB RAS), according to The
Guidelines for Manipulations of Experimental Animals.
Twenty-day-old male senescence-accelerated OXYS (n =
3), age-matched male WAG/OXYS-1.2 (n = 3) and
WAG/OXYS-1.1 (n = 3) congenic rats, and 3-month-old
WAG rats (n = 3) were obtained from the Breeding
Experimental Animal Laboratory of the Institute of Cytol-
ogy and Genetics, SB RAS (Novosibirsk, Russia). The
OXYS rat strain was derived from the Wistar strain at
the Institute of Cytology and Genetics as described earlier
[157] and registered in the Rat Genome Database [158].
At this point, we have the 105th generation of OXYS rats
who exhibit spontaneously developing cataract and accel-
erated senescence syndrome inherited in a linked man-
ner. The congenic rats were originally created as
described earlier [33,34]. At this point, we have the 13th
generation of the congenic rats who exhibit sponta-
neously developing cataract and retinopathy. At age
4 weeks, the pups were weaned, housed in groups of
5 animals per cage (57 × 36 × 20 cm), and kept under
standard laboratory conditions (22°C ± 2°C, 60% relative
humidity, and 12 h light/12 h dark cycle). The animals
were provided with standard rodent feed (PK-120-1, Ltd,
Laboratorsnab, Russia) and water ad libitum. All experi-
mental procedures were in compliance with the European
Communities Council Directive of 24 November 1986
(86/609/EEC). All efforts were made to minimize the
number of animals used and their discomfort.
Tissue preparation
All rats were euthanized by CO2 asphyxiation. After
decapitation the chorioretinal complex was excised
rapidly on ice, placed in RNALater reagent (cat.
#AM7020, Ambion), incubated at 4°C overnight in
accordance with the manufacturer’s protocol, frozen,
and stored at −70°C prior to further processing.
Sampling
The chorioretinal complex samples from three 20-day-old
OXYS and three 20-day-old WAG/OXYS-1.2 rats were
collected, processed, and sequenced individually, in tripli-
cate. For 20-day-old WAG/OXYS-1.1 rats and 3-month-
old WAG rats, 3 chorioretinal complex samples from 3
animals per strain were pooled to reduce the cost of the
experiment. The RNA-Seq data obtained for WAG strain
were not used for comparative analysis of retinal transcrip-
tional profiles, as WAG rats were of other age group.
RNA isolation
Frozen rat tissues were lysed in the TRIzol Reagent (cat.
#15596-018, Invitrogen), and total RNA was isolated
according to the manufacturer’s protocols. RNA quality
and quantity were assessed using Agilent Bioanalyser
(Agilent) and the resulting RNA concentrations were
determined using a Nanodrop 8000 spectrophotometer.
The samples were stored at −70°C until further
processing.
Illumina sequencing
More than 40 mln single-end reads 50 bp long were
obtained for each sample of retinal RNAs, using Illumina
non-stranded sequencing on an Illumina GA IIx instru-
ment at the “Genoanalitika” Lab, Moscow [159] in accor-
dance with standard Illumina protocols (mRNA-Seq
Sample Prep Kit, cat. #1004816). Briefly, polyA-tailed
mRNA was purified from total RNA using Sera-Mag Mag-
netic Oligo (dT) beads and then fragmented into small
pieces using divalent cations and heating. Using reverse
transcriptase and random primers, first- and second-
strand cDNAs were synthesized. The cDNA was processed
in an end repair reaction with T4 DNA polymerase and
Klenow DNA polymerase in order to blunt the termini.
An “A” base was then added to the 3′ end of the blunt
phosphorylated DNA fragments, and an Illumina adaptor
with a single T overhang at its 3′ end was then ligated to
the end of the DNA fragment, for hybridization in a
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single-read flow cell. After that, a size range of cDNA tem-
plates was selected, and these fragments were amplified on
a cluster station using Single-Read Cluster Generation Kit
v2. Sequencing-by-synthesis (SBS) of 50-nucleotide length
was performed using SBS v4 reagents on a Genome Ana-
lyzer IIx running the SCS2.8 software (Illumina, cat. #FC-
940-4001).
Mapping and SNP discovery
After barcode trimming, the sequencing data were
assessed for quality using the FastQC software and were
mapped to the Rattus norvegicus reference genome
assembly RGSC 5.0 (Ensemble release 75) using Bowtie
2 or TopHat v2.0.4. The SNP positions within the
aligned reads (compared to the reference genome) were
identified using the pileup function in SAMtools
(v. 0.1.17) utilities [160]. Using the various filter com-
mands, we predicted SNPs for various positions using
the minimal mapping quality (Qual) of 100. These para-
meters ensured high-quality reliable mapping of the
reads, which is important for variant calling. Using cus-
tom-made Perl scripts, we converted the VCF files into
MySQL tables. Further analysis was based on the com-
parison of SNPs specifically present in OXYS, WAG/
OXYS-1.1, WAG/OXYS-1.2, and WAG rats using
MySQL 5.0 query, Oracle Corporation [161]. The free
programming language R was used for the final data
processing and visualization [162].
Prediction of the SNP phenotypes
The SNPs–present in the specific congenic locus of chro-
mosome 1 in OXYS and congenic rats (WAG/OXYS-1.1
or WAG/OXYS-1.2) but absent in control WAG rats–
were considered possibly associated with the senescence-
accelerated phenotype. The effect of a variant (amino acid
substitution) on protein function was predicted using the
Variant Effect Predictor web tool [41]; the consequence
type, SIFT score, and prediction were calculated for each
variant. SIFT scores of 0-0.05 were classified as “deleter-
ious” and 0.05-1 - as “tolerated.”
Gene expression analysis
Sequencing data were preprocessed with Cutadapt
[163] tool in order to remove adapters and low-quality
sequences. The resulting reads were mapped on
Rnor_5.0 reference genome assembly using TopHat2
[164]. The data were then converted into gene count
tables using ENSEMBL gene annotaton data. The
resulting tables were subjected to the analysis of differ-
ential gene expression with DESeq package [37]. The
Benjamini-Hochberg correction for multiple testing
was applied to the resulting p-values, and the genes
with adjusted p-value < 0.1 were selected as differen-
tially expressed for further study. Genes that failed to
converge to Generalized Linear Model (GLM) in DE
analysis were excluded.
Pathway analysis
A bioinformatic approach was used to determine the
biological context of the large amounts of gene expres-
sion (RNA-Seq) data. Gene lists from comparative ana-
lyses showing significant differences in gene expression
were submitted to the free Database for Annotation,
Visualization, and Integrated Discovery, DAVID [38]. In
addition, functional annotation was conducted using the
WEB-based Gene SeT AnaLysis Toolkit, WebGestalt
[39,40]. All rat genes were set as a background. The
NetAge database [133] was surfed to compare the rat
DE genes from this study with human orthologs and
their partners from the annotated Alzheimer’s disease
network.
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